159 related articles for article (PubMed ID: 34868687)
1. Cosmetic Appeal, HRQoL, and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer.
Chibuzo INC; Takure AO; Shittu OB; Okeke LI
Prostate Cancer; 2021; 2021():9968570. PubMed ID: 34868687
[TBL] [Abstract][Full Text] [Related]
2. Surgical androgen deprivation therapy in advanced prostate cancer in patients of African descent: comparison of biochemical efficacy of bilateral total and subcapsular orchidectomy.
Arogundade AK; Popoola AA; Ajape AA; Abiola OO; Biliaminu SA
Afr Health Sci; 2023 Mar; 23(1):483-491. PubMed ID: 37545899
[TBL] [Abstract][Full Text] [Related]
3. Is there still a role for bilateral orchidectomy in androgen-deprivation therapy for metastatic prostate cancer?
Atta MA; Elabbady A; Sameh W; Sharafeldeen M; Elsaqa M
Arab J Urol; 2020; 18(1):9-13. PubMed ID: 32082628
[No Abstract] [Full Text] [Related]
4. Correlation Between Serum Prostate-Specific Antigen and Testosterone Following Bilateral Total Orchidectomy for Patients with Advanced Prostate Cancer in Jos, Nigeria.
Osunaiye OI; Ramyil VM; Dakum NK; Akpayak IC; Shuaibu SI; Ofoha CG; Ogunmola AO; Agbo CA; Oyedeji AS
J West Afr Coll Surg; 2023; 13(2):82-89. PubMed ID: 37228874
[TBL] [Abstract][Full Text] [Related]
5. Bilateral Orchidectomy Revisited in Management of Metastatic Hormone-Sensitive Prostate Cancer.
Agarwala A; Bansal S; Gupta NP
Indian J Surg Oncol; 2021 Sep; 12(3):565-570. PubMed ID: 34658587
[TBL] [Abstract][Full Text] [Related]
6. Epididymal sparing bilateral simple orchiectomy with epididymoplasty: preservation of esthetics and body image.
Issa MM; Lendvay TS; Bouet R; Young MR; Petros JA; Marshall FF
J Urol; 2005 Sep; 174(3):893-7. PubMed ID: 16093982
[TBL] [Abstract][Full Text] [Related]
7. Satisfaction and genital perception after orchiectomy for prostate cancer: does the technique matter? A randomized trial.
Singh O; Mukherjee P; Sakthivel MS; Wann C; George AJP; Gopalakrishnan R; Antonisamy B; Devasia A; Kumar S; Kekre NS; Chandrasingh J
Int Urol Nephrol; 2021 Aug; 53(8):1583-1589. PubMed ID: 33851360
[TBL] [Abstract][Full Text] [Related]
8. Bilateral subcapsular orchiectomy versus bilateral total orchiectomy: Comparison of the quality of life post-orchiectomy.
Orakwe DE; Tijani KH; Jeje EA; Ogunjimi MA; Rufus WO; Alabi TO
Niger Postgrad Med J; 2018; 25(1):43-47. PubMed ID: 29676345
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
Denham JW; Wilcox C; Joseph D; Spry NA; Lamb DS; Tai KH; Matthews J; Atkinson C; Turner S; Christie D; Gogna NK; Kenny L; Duchesne G; Delahunt B; McElduff P
Lancet Oncol; 2012 Dec; 13(12):1260-70. PubMed ID: 23151431
[TBL] [Abstract][Full Text] [Related]
10. Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.
Boccon-Gibod L; Fournier G; Bottet P; Marechal JM; Guiter J; Rischman P; Hubert J; Soret JY; Mangin P; Mallo C; Fraysse CE
Eur Urol; 1997; 32(4):391-5; discussion 395-6. PubMed ID: 9412794
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. A comparison of lycopene and orchidectomy vs orchidectomy alone in the management of advanced prostate cancer.
Ansari MS; Gupta NP
BJU Int; 2003 Sep; 92(4):375-8; discussion 378. PubMed ID: 12930422
[TBL] [Abstract][Full Text] [Related]
13. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
14. Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT.
Constable L; Abrams P; Cooper D; Kilonzo M; Cotterill N; Harding C; Drake MJ; Pardoe MN; McDonald A; Smith R; Norrie J; McCormack K; Ramsay C; Uren A; Mundy T; Glazener C; MacLennan G
Health Technol Assess; 2022 Aug; 26(36):1-152. PubMed ID: 35972773
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of surgical orchidectomy and medical castration in treatment efficacy, adverse effects and cost based on a large prospective metastatic prostate cancer registry.
Tan YG; Poon RJ; Pang LJ; Villanueva A; Huang HH; Chen K; Ng TK; Tay KJ; Ho HS; Yuen JS
Urol Oncol; 2020 Aug; 38(8):682.e1-682.e9. PubMed ID: 32475745
[TBL] [Abstract][Full Text] [Related]
16. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2014 Sep; 15(10):1076-89. PubMed ID: 25130995
[TBL] [Abstract][Full Text] [Related]
17. CO2 laser subcapsular orchidectomy in the treatment of metastatic prostate cancer.
Bolton DM; Costello AJ
Lasers Surg Med; 1994; 14(1):88-9. PubMed ID: 8127213
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy.
Banerji JS; Hurwitz LM; Cullen J; Wolff EM; Levie KE; Rosner IL; Brand TC; LʼEsperance JO; Sterbis JR; Porter CR
Urol Oncol; 2017 May; 35(5):234-242. PubMed ID: 28110975
[TBL] [Abstract][Full Text] [Related]
19. Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial.
Saad F; Thiery-Vuillemin A; Wiechno P; Alekseev B; Sala N; Jones R; Kocak I; Chiuri VE; Jassem J; Fléchon A; Redfern C; Kang J; Burgents J; Gresty C; Degboe A; Clarke NW
Lancet Oncol; 2022 Oct; 23(10):1297-1307. PubMed ID: 36063830
[TBL] [Abstract][Full Text] [Related]
20. Potency preservation following stereotactic body radiation therapy for prostate cancer.
Obayomi-Davies O; Chen LN; Bhagat A; Wright HC; Uhm S; Kim JS; Yung TM; Lei S; Batipps GP; Pahira J; McGeagh KG; Collins BT; Kowalczyk K; Bandi G; Kumar D; Suy S; Dritschilo A; Lynch JH; Collins SP
Radiat Oncol; 2013 Nov; 8():256. PubMed ID: 24180317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
